Glaucoma Drainage Device Coated with Mitomycin C Loaded Opal Shale Microparticles to Inhibit Bleb Fibrosis.
Aimeng DongLiang HanZhengbo ShaoPan FanXinrong ZhouHuiping YuanPublished in: ACS applied materials & interfaces (2019)
Excessive fibrosis is the topmost factor for the defeat of surgical glaucoma drainage device (GDD) implantation. Adjuvant drug approaches are promising to help reduce the scar formation and excessive fibrosis. Opal shale (OS), as a natural state and noncrystalline silica substance with poriferous nature and strong adsorbability, is highly likely to undertake drug loading and delivery. Here, we employed OS microparticles (MPs) by ultrasound and centrifugation and presented an innovative and improved GDD coated with OS MPs, which were loaded with mitomycin C (MMC). MMC-loaded OS MPs were physically absorbed on the Ahmed glaucoma valve surface through OS' adsorbability. About 5.51 μg of MMC was loaded on the modified Ahmed glaucoma valve and can be released for 18 days in vitro. MMC-loaded OS MPs inhibited fibroblast proliferation and showed low toxicity to primary Tenon's fibroblasts. The ameliorated drainage device was well tolerated and effective in reducing the fibrous reaction in vivo. Hence, our study constructed an improved Ahmed glaucoma valve using OS MPs without disturbing aqueous humor drainage pattern over the valve surface. The modified Ahmed glaucoma valve successfully alleviated scar tissue formation after GDD implantation surgery.
Keyphrases
- aortic valve
- mitral valve
- drug delivery
- wound healing
- optic nerve
- aortic stenosis
- ultrasound guided
- cancer therapy
- transcatheter aortic valve replacement
- cataract surgery
- minimally invasive
- magnetic resonance imaging
- emergency department
- weight gain
- oxidative stress
- ejection fraction
- heart failure
- coronary artery disease
- left ventricular
- physical activity
- liver fibrosis
- percutaneous coronary intervention